BTA 0.00% 57.0¢ biota holdings limited

You can't seriously imagine GSK could BTA by paying $2.35/share...

  1. 1,373 Posts.
    You can't seriously imagine GSK could BTA by paying $2.35/share do you? Who would agree to that? A takeover premium would price it closer to $12 with all the associated hype around vastly increased demand for Relenza, LANI and other BTA blue sky projects. I also doubt Costello would wear it given adverse publicity surounding the court case and Sankyo would be highly resistant as a JV partner.
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.